Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/jmv.26593 http://scihub22266oqcxt.onion/10.1002/jmv.26593 33044760!7675642!33044760     free     free     free Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 215.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Med+Virol 2021 ; 93 (3): 1314-1319 Nephropedia Template TP {{tp|p=33044760|t=2021. Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients |pdf=|usr=}}{{33044760}} gab.com Text Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients JO: J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=33044760 #FOAvip Recent evidence suggested that neurological manifestations occur in patients with a severe form of coronavirus disease (COVID-19). On the basis of this issue, neurologists are very concerned about patients with neurological disorders, especially multiple sclerosis (MS), as consumers of immunosuppressive or immune-modulating drugs. Therefore, the administration of proper disease-modifying therapies (DMTs) in MS patients is critical during the pandemic status. On the one hand, both the autoimmune diseases and immunosuppressive drugs increase the risk of infection due to impairment in the immune system, and on the other hand, postponing of MS treatment has serious consequences on the central nervous system. In the present study, we discussed recent literature about the effect of DMTs administration on the severity of COVID-19 in the MS patients. Overall, it seems that DMTs do not provoke the COVID-19 infection in the MS patients by declining immune responses and cytokine storm. However, as a precaution, the supervision of a neurologist is highly recommended. Twit Text FOAVip Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients ????J Med Virol http://www.kidney.de/pget.php?&tw=1&pmid=33044760 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33044760 #FOAvip English Wikipedia <ref>{{Cite pmid|33044760}}</ref> Impact of disease-modifying drugs on the severity of COVID-19 infection in multiple sclerosis patients #MMPMID33044760 Rostami Mansoor S; Ghasemi-Kasman M J Med Virol 2021[Mar]; 93 (3): 1314-1319 PMID33044760show ga Recent evidence suggested that neurological manifestations occur in patients with a severe form of coronavirus disease (COVID-19). On the basis of this issue, neurologists are very concerned about patients with neurological disorders, especially multiple sclerosis (MS), as consumers of immunosuppressive or immune-modulating drugs. Therefore, the administration of proper disease-modifying therapies (DMTs) in MS patients is critical during the pandemic status. On the one hand, both the autoimmune diseases and immunosuppressive drugs increase the risk of infection due to impairment in the immune system, and on the other hand, postponing of MS treatment has serious consequences on the central nervous system. In the present study, we discussed recent literature about the effect of DMTs administration on the severity of COVID-19 in the MS patients. Overall, it seems that DMTs do not provoke the COVID-19 infection in the MS patients by declining immune responses and cytokine storm. However, as a precaution, the supervision of a neurologist is highly recommended. |Animals[MESH] |COVID-19/immunology/*pathology[MESH] |Humans[MESH] |Immunologic Factors/immunology/*therapeutic use[MESH] |Immunosuppressive Agents/immunology/*therapeutic use[MESH] |Multiple Sclerosis/*drug therapy/immunology[MESH] |Pandemics/prevention & control[MESH] |SARS-CoV-2/immunology[MESH]Impact of disease-modifying drugs on the severity of COVID-19 infecti(epmc).pdf DeepDyve Pubget Overpricing